Proteomics Market to Grow at 16.8% CAGR Through 2031 | North America Leads with ~37.5% Share | Drug Discovery Dominates | Key Players: Thermo Fisher, Danaher, Agilent, Bruker

The global proteomics market is growing at a CAGR of 16.8% during the forecast period 2024 to 2031, according to DataM Intelligence.

United States: Recent Industry Developments
✅ In 2025-2026, Thermo Fisher Scientific continued momentum from its 2024 acquisition of Olink Holding AB (valued at $3.1 billion), enhancing precision proteomics and biomarker discovery capabilities with next-generation assays.
✅ In October 2024 (carrying into 2025), Thermo Fisher launched the Thermo Scientific iCAP MX Series ICP-MS, including single and triple quadrupole systems for advanced trace element analysis in proteomics workflows.
✅ In 2025, advancements in single-cell proteomics and AI-integrated platforms supported NIH-funded programs and precision medicine initiatives.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/proteomics-market?sindhuri
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Japan: Recent Industry Developments
✅ In 2024-2025, Japan's focus on personalized medicine drove proteomics research at institutions like RIKEN and Kyoto University, with applications in regenerative medicine, oncology, and early Alzheimer's detection funded by the Ministry of Health.
✅ Ongoing collaborations with global leaders for high-resolution mass spectrometry and biomarker studies aligned with national health priorities.
✅ Emphasis on proteomics in neurodegenerative and cancer research to support aging population needs.

Asia-Pacific: Rapid Industry Developments
✅ In 2025, China expanded proteomics in drug discovery and clinical diagnostics, supported by rising R&D investments and biopharma growth.
✅ In India, increasing healthcare infrastructure and research collaborations boosted demand for proteomics tools in biomarker identification and personalized therapies.
✅ Regional growth driven by government initiatives, academic partnerships, and adoption of advanced mass spectrometry for disease pathogenesis studies.

Mergers & Acquisitions
✅ July 2024: Thermo Fisher Scientific completed the acquisition of Olink to expand proteomics capabilities in precision medicine and biomarker discovery.
✅ February 2022 (ongoing impact): Agilent Technologies acquired ACIES AI technology from Virtual Control for integration into GC-MS platforms.
✅ Strategic consolidations among leaders like Danaher and others to bolster multi-omics and proteomics portfolios.

Buy now and enjoy discounts - limited-time offer!
https://www.datamintelligence.com/buy-now-page?report=proteomics-market?sindhuri

Technological Partnerships
✅ November 2021 (renewed impact): Thermo Fisher Scientific renewed collaborative marketing agreement with Biognosys for high-throughput plasma proteomics workflows.
✅ Partnerships between key players (e.g., Bruker, Agilent) and research institutions for AI/ML integration and advanced mass spectrometry developments.
✅ Collaborations advancing single-cell and high-plex proteomics platforms for drug discovery and clinical applications.

New Product/Service Launch
✅ June 2023 (with continued adoption): Bruker Corporation introduced the timsTOF Ultra mass spectrometer featuring 4th-generation trapped ion mobility, 14-bit digitizer, and CSI Ultra ion source for superior proteomics sensitivity.
✅ March 2023: Thermo Fisher Scientific launched the PAC Neo low-load trapping column for single-cell proteomics separations compatible with Vanquish Neo UHPLC.
✅ October 2024: Agilent Technologies launched next-generation InfinityLab LC Series (1290/1260 Infinity III systems) for enhanced proteomics lab efficiency.

Technological Advancements in the Market
✅ Breakthroughs in mass spectrometry (e.g., high-resolution Orbitrap, timsTOF) and AI quantitation for deeper proteome profiling, single-cell analysis, and biomarker discovery.
✅ Advancements in chromatography, spectroscopy, and protein microarrays improving sensitivity, throughput, and accuracy in complex samples.
✅ Integration of proteomics with multi-omics, precision medicine, and bioinformatics for better understanding of disease mechanisms and therapeutic targets.

Funding Raised by Companies
✅ Significant R&D investments by major players like Thermo Fisher, Bruker, and Agilent in next-gen instruments and AI-driven proteomics.
✅ Government and NIH funding (e.g., programs supporting single-cell proteomics) driving innovation and infrastructure in the U.S. and globally.
✅ Corporate commitments to proteomics for cancer biomarkers, drug discovery, and personalized healthcare.

Market Dynamics & Key Insights
✅ Rising focus on biomarker discovery for cancer and other diseases, increasing R&D investments, collaborations for drug discovery, and technological advancements in mass spectrometry and proteomics workflows.
✅ Drug discovery dominates applications (~56.1% share), driven by need for pathogenesis understanding and targeted therapies; clinical diagnostics growing rapidly.
✅ High costs, sample inconsistencies, and data challenges as restraints, but opportunities in precision medicine, personalized healthcare, and emerging markets.
✅ North America leads due to major players, research infrastructure, and healthcare spending; Asia-Pacific fastest-growing with industrialization and investments.

Segmentation
By Instrumentation Technology
Chromatography, Protein Microarrays, Spectroscopy (dominant due to accuracy in protein detection), Electrophoresis, X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation, Others.
By Application
The Drug Discovery segment dominates with ~56.1% market share, fueled by biomarker identification and therapeutic development.
Clinical Diagnostics (fastest-growing), Others.
By Services and Software
Bioinformatics Software and Services, Core Proteomics Services, Reagents (significant recurring revenue).
By End User
Biopharmaceutical Companies, Research Laboratories, Hospitals.

Regional Analysis
North America leads the global proteomics market with ~37.5% share (2022 data, continued dominance), supported by major players (Thermo Fisher, Danaher), high R&D investments, technological advancements, and strong pharmaceutical/biotech presence.
Asia-Pacific is the fastest-growing region, driven by rising research, healthcare infrastructure in China and India, and increasing focus on personalized medicine.
Europe holds solid position with academic and industry collaborations.
Latin America, Middle East & Africa show emerging growth.

Speak to Our Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/proteomics-market?sindhuri

Competitive Landscape
Key players include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Merck KGaA, Promega Corporation, Waters Corporation, PerkinElmer Inc., and others. Companies drive growth through product launches, acquisitions (e.g., Olink by Thermo Fisher), AI integrations, and advancements in mass spectrometry and proteomics workflows.

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.

This release was published on openPR.